R

Regeneron Pharmaceuticals

Develops biopharmaceutical therapies for serious diseases

Senior Director - Global Patient Safety, Rare Disease

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-time$242k - $403.3k /yr

About the Job

Requirements

  • The role requires either 5 or more years of total relevant experience in pharmacovigilance and/or a relevant medical field with a PharmD, PhD, or MD, or 15 or more years of total relevant experience in pharmacovigilance and/or a relevant medical field, or equivalent in-lieu industry experience in drug safety including significant experience with PSURs, DSURs, and (d)RMPs, or clinical development with demonstrated safety achievements such as supporting an ISS or being responsible for CSR content.
  • Demonstrated experience in specialty therapeutic areas incorporating advanced therapies, such as gene therapy, into pharmacovigilance practices.
  • Ability to apply and provide critical analysis of relevant FDA, EU, and ICH guidelines, initiatives, and regulations governing pharmacovigilance activities in clinical-trial and post-marketing environments.
  • Relevant clinical industry experience in the therapeutic area of interest and ability to function as a subject matter expert internally and externally to Global Patient Safety for assigned compounds.
  • Thorough understanding of drug development and its context as applicable to safety surveillance activities.
  • Ability to lead and develop a diverse team of safety professionals in a constructive, goal-oriented environment.
  • Ability to work across organizational levels, communicate safety viewpoints and findings effectively, and recommend risk-management and minimization activities.
  • Ability to use the Global Patient Safety safety database for medical case review and simple queries.

Responsibilities

  • Serve as the first point of contact for all safety-related issues for assigned compounds within the therapeutic area.
  • Be directly responsible for Global Patient Safety activities for assigned compounds and products, including safety surveillance, signal management, communication of the safety profile appropriate to the asset lifecycle stage, benefit-risk assessment, safety responses to regulatory agency queries, safety documents such as DSURs, PSURs, development RMPs and RMPs, and review of clinical documents such as Investigator Brochures, protocols, and clinical study reports.
  • Represent Global Patient Safety on the cross-functional Strategic Program Team and chair the Safety Management Team for the compound.
  • Lead the safety strategy, ensure optimal support from within Global Patient Safety, and collaborate with stakeholders to deliver the safety profile and strategy.
  • Lead cross-functional Safety Monitoring Team activities and represent Global Patient Safety for assigned compounds on cross-functional teams, including the Safety Oversight Committee, Independent Data Monitoring Committees, Strategic Program Team, and teams with external members such as alliance partners and contract research organizations.
  • Serve as delegate for the Global Patient Safety Therapeutic Area Head, General Medicine, as needed.
  • Proactively identify and develop safety strategies and plans for non-compound-specific Global Patient Safety activities, including mechanism of action.
  • Act as a resource for medical review of complex individual case safety reports and other data sources for assigned compounds.
  • Participate in developing and maintaining relevant standard operating procedures, working practices, and guides.
  • Participate in continuous-improvement activities within the therapeutic area and Global Patient Safety, cultivate cross-functional relationships, and mentor junior safety scientists.

About the Company

Regeneron Pharmaceuticals

Develops biopharmaceutical therapies for serious diseases

Regeneron Pharmaceuticals develops and commercializes medicines for serious diseases, with a focus on cancer, eye diseases, allergic and inflammatory diseases, and infectious diseases. Its products come from using proprietary research capabilities and technologies to discover and develop therapies, often in collaboration with academic, research, and industry partners. Revenue comes from selling approved medicines and from licensing its technologies and entering co-development and co-commercialization partnerships. The company works with healthcare providers and regulators to ensure treatment delivery and safety. Its goal is to improve patient outcomes by bringing life-transforming medicines to market through rigorous R&D and strategic collaborations, maintaining leadership in biopharmaceutical innovation.

Company size
10,001+
Company stage
IPO
Headquarters
Town of Mount Pleasant, New York
Founded
1988

Recently Posted Jobs

Explore more opportunities at Regeneron Pharmaceuticals

See more jobs